Jim Simons Orchard Therapeutics PLC Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.36 - $0.49 $249,537 - $339,647	-693,159 Reduced 27.34%	1,842,280 $683,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.69 $247,117 - $378,914	549,151 Added 27.65%	2,535,439 $1.27 Million
Q2 2022 Aug 12, 2022	BUY	$0.42 - $0.78 $492,350 - $914,365	1,172,263 Added 144.01%	1,986,288 $1.16 Million
Q1 2022 May 13, 2022	SELL	$0.7 - $1.51 $113,386 - $244,589	-161,980 Reduced 16.6%	814,025 $580,000
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.23 $102,513 - $197,074	-88,374 Reduced 8.3%	976,005 $1.29 Million
Q3 2021 Nov 12, 2021	BUY	$2.24 - $4.29 $2.16 Million - $4.14 Million	964,379 Added 964.38%	1,064,379 $2.45 Million
Q2 2021 Aug 13, 2021	BUY	$4.39 - $7.23 $438,999 - $723,000	100,000 New	100,000 $439,000
Q1 2021 May 13, 2021	SELL	$4.39 - $9.08 $759,790 - $1.57 Million	-173,073 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.86 - $5.07 $515,437 - $677,012	133,533 Added 337.72%	173,073 $748,000
Q3 2020 Nov 13, 2020	SELL	$4.11 - $6.45 $2.43 Million - $3.81 Million	-590,860 Reduced 93.73%	39,540 $163,000
Q2 2020 Aug 13, 2020	BUY	$5.75 - $11.99 $2.15 Million - $4.47 Million	373,200 Added 145.1%	630,400 $3.78 Million
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $1.32 Million - $3.67 Million	233,500 Added 985.23%	257,200 $1.94 Million
Q4 2019 Feb 13, 2020	BUY	$10.15 - $15.58 $240,555 - $369,246	23,700 New	23,700 $326,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.